A citation-based method for searching scientific literature

Thaiany Quevedo Melo, Sjef J C V M Copray, Merari F R Ferrari. Neurochem Res 2018
Times Cited: 15







List of co-cited articles
195 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
M H Polymeropoulos, C Lavedan, E Leroy, S E Ide, A Dehejia, A Dutra, B Pike, H Root, J Rubenstein, R Boyer,[...]. Science 1997
33

Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
Victorio M Pozo Devoto, Tomas L Falzone. Dis Model Mech 2017
74
33

Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
26

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.
Latha Devi, Vijayendran Raghavendran, Badanavalu M Prabhu, Narayan G Avadhani, Hindupur K Anandatheerthavarada. J Biol Chem 2008
642
26

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
26

Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes.
Wenzhang Wang, Xinglong Wang, Hisashi Fujioka, Charles Hoppel, Alan L Whone, Maeve A Caldwell, Peter J Cullen, Jun Liu, Xiongwei Zhu. Nat Med 2016
177
26

VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function.
Fu-Lei Tang, Wei Liu, Jin-Xia Hu, Joanna Ruth Erion, Jian Ye, Lin Mei, Wen-Cheng Xiong. Cell Rep 2015
148
26

Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
Ira E Clark, Mark W Dodson, Changan Jiang, Joseph H Cao, Jun R Huh, Jae Hong Seol, Soon Ji Yoo, Bruce A Hay, Ming Guo. Nature 2006
26

Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.
Yufeng Yang, Stephan Gehrke, Yuzuru Imai, Zhinong Huang, Yingshi Ouyang, Ji-Wu Wang, Lichuan Yang, M Flint Beal, Hannes Vogel, Bingwei Lu. Proc Natl Acad Sci U S A 2006
566
26

Mitochondrial complex I deficiency in Parkinson's disease.
A H Schapira, J M Cooper, D Dexter, P Jenner, J B Clark, C D Marsden. Lancet 1989
26

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
20

Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies.
He-Jin Lee, Ji-Eun Suk, Christina Patrick, Eun-Jin Bae, Ji-Hoon Cho, Sangchul Rho, Daehee Hwang, Eliezer Masliah, Seung-Jae Lee. J Biol Chem 2010
515
20

Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
Lena F Burbulla, Pingping Song, Joseph R Mazzulli, Enrico Zampese, Yvette C Wong, Sohee Jeon, David P Santos, Judith Blanz, Carolin D Obermaier, Chelsee Strojny,[...]. Science 2017
311
20


Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function.
Heather Snyder, Kwame Mensah, Catherine Theisler, Jack Lee, Andreas Matouschek, Benjamin Wolozin. J Biol Chem 2003
302
20

Subcellular localization of alpha-synuclein aggregates and their interaction with membranes.
Fabiana Miraglia, Alessio Ricci, Lucia Rota, Emanuela Colla. Neural Regen Res 2018
28
20

Mitochondrial dysfunction associated with glucocerebrosidase deficiency.
Matthew E Gegg, Anthony H V Schapira. Neurobiol Dis 2016
57
20

Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.
Y Mizuno, S Ohta, M Tanaka, S Takamiya, K Suzuki, T Sato, H Oya, T Ozawa, Y Kagawa. Biochem Biophys Res Commun 1989
614
20


Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease.
Christian Dölle, Irene Flønes, Gonzalo S Nido, Hrvoje Miletic, Nelson Osuagwu, Stine Kristoffersen, Peer K Lilleng, Jan Petter Larsen, Ole-Bjørn Tysnes, Kristoffer Haugarvoll,[...]. Nat Commun 2016
116
20

The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
Jin-Sung Park, Nicholas F Blair, Carolyn M Sue. Mov Disord 2015
87
20


p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both.
Derek Narendra, Lesley A Kane, David N Hauser, Ian M Fearnley, Richard J Youle. Autophagy 2010
513
20

PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?
Dominika Truban, Xu Hou, Thomas R Caulfield, Fabienne C Fiesel, Wolfdieter Springer. J Parkinsons Dis 2017
114
20

Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control.
Gian-Luca McLelland, Vincent Soubannier, Carol X Chen, Heidi M McBride, Edward A Fon. EMBO J 2014
393
20

A new pathway for mitochondrial quality control: mitochondrial-derived vesicles.
Ayumu Sugiura, Gian-Luca McLelland, Edward A Fon, Heidi M McBride. EMBO J 2014
370
20

PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility.
Xinnan Wang, Dominic Winter, Ghazaleh Ashrafi, Julia Schlehe, Yao Liang Wong, Dennis Selkoe, Sarah Rice, Judith Steen, Matthew J LaVoie, Thomas L Schwarz. Cell 2011
746
20


The Close Encounter Between Alpha-Synuclein and Mitochondria.
Mattia Vicario, Domenico Cieri, Marisa Brini, Tito Calì. Front Neurosci 2018
58
20

The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy.
Victoria S Burchell, David E Nelson, Alvaro Sanchez-Martinez, Marta Delgado-Camprubi, Rachael M Ivatt, Joe H Pogson, Suzanne J Randle, Selina Wray, Patrick A Lewis, Henry Houlden,[...]. Nat Neurosci 2013
183
20

Soluble, prefibrillar α-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction.
Eric S Luth, Irina G Stavrovskaya, Tim Bartels, Bruce S Kristal, Dennis J Selkoe. J Biol Chem 2014
158
20

Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.
Jin-Sung Park, Ryan L Davis, Carolyn M Sue. Curr Neurol Neurosci Rep 2018
174
20

Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.
Jeehye Park, Sung Bae Lee, Sungkyu Lee, Yongsung Kim, Saera Song, Sunhong Kim, Eunkyung Bae, Jaeseob Kim, Minho Shong, Jin-Man Kim,[...]. Nature 2006
20


α-Synuclein impairs macroautophagy: implications for Parkinson's disease.
Ashley R Winslow, Chien-Wen Chen, Silvia Corrochano, Abraham Acevedo-Arozena, David E Gordon, Andrew A Peden, Maike Lichtenberg, Fiona M Menzies, Brinda Ravikumar, Sara Imarisio,[...]. J Cell Biol 2010
508
20

PINK1 is degraded through the N-end rule pathway.
Koji Yamano, Richard J Youle. Autophagy 2013
329
20

Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment.
Andrew W Greene, Karl Grenier, Miguel A Aguileta, Stephanie Muise, Rasoul Farazifard, M Emdadul Haque, Heidi M McBride, David S Park, Edward A Fon. EMBO Rep 2012
385
20

PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling.
Vanessa A Morais, Dominik Haddad, Katleen Craessaerts, Pieter-Jan De Bock, Jef Swerts, Sven Vilain, Liesbeth Aerts, Lut Overbergh, Anne Grünewald, Philip Seibler,[...]. Science 2014
206
20

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.
Andreas Bender, Kim J Krishnan, Christopher M Morris, Geoffrey A Taylor, Amy K Reeve, Robert H Perry, Evelyn Jaros, Joshua S Hersheson, Joanne Betts, Thomas Klopstock,[...]. Nat Genet 2006
982
20

Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL.
Seok Min Jin, Michael Lazarou, Chunxin Wang, Lesley A Kane, Derek P Narendra, Richard J Youle. J Cell Biol 2010
741
20

alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity.
Guangwei Liu, Chunyan Zhang, Juanjuan Yin, Xin Li, Furong Cheng, Yaohua Li, Hui Yang, Kenji Uéda, Piu Chan, Shun Yu. Neurosci Lett 2009
130
20

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
P Anglade, S Vyas, F Javoy-Agid, M T Herrero, P P Michel, J Marquez, A Mouatt-Prigent, M Ruberg, E C Hirsch, Y Agid. Histol Histopathol 1997
793
13


Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
Dongdong Chen, Jinhwan Lee, Xiaohuan Gu, Ling Wei, Shan Ping Yu. ASN Neuro 2015
60
13

Progress of immunotherapy of anti-α-synuclein in Parkinson's disease.
Zhipeng Wang, Ge Gao, Chunli Duan, Hui Yang. Biomed Pharmacother 2019
25
13

Structure and dynamics of micelle-bound human alpha-synuclein.
Tobias S Ulmer, Ad Bax, Nelson B Cole, Robert L Nussbaum. J Biol Chem 2005
572
13

Structural and functional implications of C-terminal regions of alpha-synuclein.
Thomas D Kim, Seung R Paik, Chul-Hak Yang. Biochemistry 2002
124
13

DJ-1 has a role in antioxidative stress to prevent cell death.
Takahiro Taira, Yoshiro Saito, Takeshi Niki, Sanae M M Iguchi-Ariga, Kazuhiko Takahashi, Hiroyoshi Ariga. EMBO Rep 2004
653
13

Review: Parkinson's disease: from synaptic loss to connectome dysfunction.
Arianna Bellucci, Nicola Biagio Mercuri, Annalena Venneri, Gaia Faustini, Francesca Longhena, Marina Pizzi, Cristina Missale, PierFranco Spano. Neuropathol Appl Neurobiol 2016
93
13



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.